Picture of genOway SA logo

ALGEN — genOway SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Genoway H1 EBITDA Rises To 2.3 Million Euros

Sept 21 - Genoway SA  ALGEN.PA :
    * H1 CONSOLIDATED TURNOVER EUR 9.3 MILLION VERSUS EUR 7.8
MILLION
YR AGO
    * H1 EBITDA EUR 2.3 MILLION VERSUS EUR 1.4 MILLION YR AGO
    * H1 NET PROFIT EUR 1.0 MILLION VS EUR 0.2 MILLION YR AGO 
    * GROWTH IN SALES SHOULD CONTINUE DURING H2 WITH AIM OF
EXCEEDING
THRESHOLD OF EUR 20 MILLION IN 2023 
    * PROFITABILITY SHOULD REMAIN AT A HIGH LEVEL, CLOSE TO THAT
SEEN
IN H1 2023
    * WILL UNVEIL ITS NEW 5-YEAR STRATEGIC PLAN AT END-NOVEMBER
2023

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nNDL6ZFb9S
 Further company coverage:  ALGEN.PA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on genOway SA

See all news